The Athos SAB Chair, Dr. Claudio Fiocchi and the Athos CEO, Dr. Dimitrios Iliopoulos, have published an intriguing and informative article regarding the power of systems biology and how it relates to the treatment of IBD in Inflammatory Bowel Diseases (the official journal for the Crohn’s & Colitis Foundation) (view pdf here). The article discusses why systems biology, because it is based on the utilization of unbiased computational data, is becoming indispensable in the medical community’s collective effort to produce increasingly safe and efficacious medicines.
